1. World Health Organisation. Medication without harm: global patient safety challenge. Geneva: World Health Organisation; 2017.
2. Ostini R, Roughead EE, Kirkpatrick CM, Monteith GR, Tett SE. Quality use of medicines–medication safety issues in naming; look-alike, sound-alike medicine names. Int J Pharm Pract. 2012;20(6):349–57.
3. Goedecke T, Ord K, Newbould V, Brosch S, Arlett P. Medication errors: new EU good practice guide on risk minimisation and error prevention. Drug Saf. 2016;39(6):491–500.
4. Union European. Directive 2010/84/EU of the European Parliament and of the Council of 15 December 2010 amending as regards pharmacovigilance, Directive 2001/83/EC on the Community code relating to medicinal products for human use. Off J Eur Union. 2010;L348(53):74–99. Found on: https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2010:348:0074:0099:EN:PDF.
5. European Union. Regulation (EU) No 1235/2010 of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmacovigilance of medicinal products for human use, Regulation (EC) No 726/2004 laying down Community procedures for the authorisation. Off J Eur Union. 2010;348(726). Found on: https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2010:348:0001:0016:EN:PDF.